# Optimising Rotavirus Vaccine in Aboriginal Children

> **NCT02941107** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Telethon Kids Institute** · enrollment: 1000 (estimated)

## Conditions studied

- Viral Gastroenteritis Due to Rotavirus

## Interventions

- **DRUG:** Rotarix (RV1)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02941107
- **Lead sponsor:** Telethon Kids Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-03-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02941107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02941107, "Optimising Rotavirus Vaccine in Aboriginal Children". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02941107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*